[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Investigation
July 2016

Quantitative Fundus Autofluorescence in Early and Intermediate Age-Related Macular Degeneration

Author Affiliations
  • 1Department of Ophthalmology, University Hospital of Bonn, Bonn, Germany
  • 2Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
JAMA Ophthalmol. 2016;134(7):817-824. doi:10.1001/jamaophthalmol.2016.1475

Importance  Increased lipofuscin accumulation is assumed to be an important factor in the pathogenesis of age-related macular degeneration (AMD), although direct evidence for this hypothesis is missing.

Objective  To quantitatively investigate lipofuscin-associated fundus autofluorescence (AF) in patients with early and intermediate AMD.

Design, Setting, and Participants  A prospective, single-center, case-control study was conducted from August 1, 2014, to October 31, 2015, at a university referral center. Participants included 40 patients aged 65 years or younger and 108 individuals without eye disease serving as controls. All participants underwent quantitative fundus AF (qAF) imaging with a modified scanning laser ophthalmoscope equipped with an internal fluorescent reference. Mean qAF values of an 8-segment circular ring centered on the fovea (qAF8) were measured and compared between patients and controls. For subgroup analysis, drusen were categorized as soft drusen, cuticular drusen, and/or reticular pseudodrusen (RPD).

Main Outcomes and Measures  The qAF8 levels.

Results  In the 40 patients with AMD, mean (SD) age was 54.8 (5.6) years, and 32 (80%) were women. None of the investigated patients had qAF8 values above the 95% prediction interval (PI) of the 108 controls. In the soft drusen (28 [70%]) and cuticular drusen (8 [20%]) groups, qAF8 levels within the 95% PI were noted in 22 patients (79%; 95% CI, 60% to 90%) and 7 patients (88%; 95% CI, 51% to 99%) respectively. The qAF8 values in the RPD group (4 [10%]) were below the 95% PI in 3 patients (75%; 95% CI, 29% to 97%). Compared with the controls, statistical analysis revealed lower qAF8 values in the overall AMD cohort after adjusting for age (difference, −19.9% [95% CI, −25.6% to −12.7%], P < .001) as well as in all subgroups (soft drusen, −17.1% [95% CI, −24.1% to −9.5%], P < .001; cuticular drusen, −19.6% [95% CI, −30.3% to −7.2%], P = .003; and RPD, −34.5% [95% CI, −47.1% to −21.3%]; P < .001).

Conclusions and Relevance  The qAF8 measurements in this sample showed no increased lipofuscin-related fundus AF in patients with early and intermediate AMD. Lower qAF levels in certain subgroups may point to subnormal lipofuscin levels in the retinal pigment epithelium or, alternatively, limitations to detection of true retinal pigment epithelial lipofuscin content. The results of this study might expand the understanding of the pathogenesis of AMD and may have an effect on upcoming treatment trials that aim to modify lipofuscin accumulation.